Candriam SCA’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.94M | Sell |
223,990
-1,806
| -0.8% | -$23.7K | 0.02% | 435 |
|
|
2025
Q1 | $4.97M | Sell |
225,796
-28,169
| -11% | -$620K | 0.03% | 329 |
|
|
2024
Q4 | $6.78M | Sell |
253,965
-40,659
| -14% | -$1.09M | 0.04% | 314 |
|
|
2024
Q3 | $7.86M | Sell |
294,624
-34,376
| -10% | -$917K | 0.05% | 298 |
|
|
2024
Q2 | $5.93M | Hold |
329,000
| – | – | 0.04% | 318 |
|
|
2024
Q1 | $6M | Buy |
329,000
+21,000
| +7% | +$383K | 0.04% | 311 |
|
|
2023
Q4 | $3.37M | Buy |
308,000
+10,000
| +3% | +$109K | 0.02% | 395 |
|
|
2023
Q3 | $1.71M | Hold |
298,000
| – | – | 0.01% | 471 |
|
|
2023
Q2 | $2.31M | Hold |
298,000
| – | – | 0.02% | 472 |
|
|
2023
Q1 | $1.83M | Hold |
298,000
| – | – | 0.01% | 594 |
|
|
2022
Q4 | $2.66M | Buy |
298,000
+108,000
| +57% | +$965K | 0.02% | 522 |
|
|
2022
Q3 | $1.87M | Buy |
+190,000
| New | +$1.87M | 0.01% | 594 |
|